|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 296.40 SEK | -0.13% |
|
-2.95% | +32.77% |
| 09/07 | Mycronic expected to post SEK 554m in operating profit - Modular | FW |
| 09/07 | Lannebo Small Cap Opportunities fell 2.2% in June, Dynavox, Nordic Semiconductor and Sinch weighed | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.48 | 7.97 | 9.97 | 13.44 | 12.23 | |||||
Return on Total Capital | 16.68 | 11.65 | 14.92 | 20.48 | 18.31 | |||||
Return On Equity % | 22.43 | 16.94 | 19.95 | 28.47 | 22.8 | |||||
Return on Common Equity | 22.63 | 17.2 | 20.14 | 28.58 | 22.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.92 | 44.7 | 50.05 | 52.73 | 52.94 | |||||
SG&A Margin | 16.59 | 17.37 | 17.46 | 14.01 | 14.78 | |||||
EBITDA Margin % | 24.31 | 19.42 | 24.33 | 30.4 | 28.47 | |||||
EBITA Margin % | 23.15 | 18.21 | 23.03 | 29.36 | 27.37 | |||||
EBIT Margin % | 22.7 | 16.78 | 21.92 | 28.57 | 26.3 | |||||
Income From Continuing Operations Margin % | 17.84 | 14.4 | 17.46 | 23.92 | 19.65 | |||||
Net Income Margin % | 17.86 | 14.48 | 17.49 | 23.85 | 19.65 | |||||
Net Avail. For Common Margin % | 17.86 | 14.48 | 17.49 | 23.85 | 19.65 | |||||
Normalized Net Income Margin | 14.53 | 10.68 | 13.86 | 18.4 | 16.07 | |||||
Levered Free Cash Flow Margin | 11.21 | 14.16 | 18.14 | 18.24 | 10.4 | |||||
Unlevered Free Cash Flow Margin | 11.4 | 14.32 | 18.28 | 18.37 | 10.53 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.81 | 0.76 | 0.73 | 0.75 | 0.74 | |||||
Fixed Assets Turnover | 10.36 | 10.87 | 11.32 | 13.2 | 12.47 | |||||
Receivables Turnover (Average Receivables) | 6.39 | 5.19 | 4.56 | 4.9 | 5.15 | |||||
Inventory Turnover (Average Inventory) | 1.82 | 2.03 | 1.88 | 1.82 | 1.78 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.05 | 2.03 | 2.12 | 2.15 | 2.3 | |||||
Quick Ratio | 1.03 | 1.31 | 1.46 | 1.48 | 1.5 | |||||
Operating Cash Flow to Current Liabilities | 0.64 | 0.41 | 0.64 | 0.58 | 0.5 | |||||
Days Sales Outstanding (Average Receivables) | 57.13 | 70.34 | 79.96 | 74.74 | 70.81 | |||||
Days Outstanding Inventory (Average Inventory) | 200.03 | 180.24 | 194.35 | 200.66 | 205.46 | |||||
Average Days Payable Outstanding | 40.54 | 38.06 | 42.19 | 45.63 | 48.7 | |||||
Cash Conversion Cycle (Average Days) | 216.63 | 212.52 | 232.11 | 229.77 | 227.57 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.08 | 5.74 | 4.32 | 3.35 | 4.9 | |||||
Total Debt / Total Capital | 5.73 | 5.43 | 4.14 | 3.24 | 4.67 | |||||
LT Debt/Equity | 4.53 | 4.1 | 2.84 | 2.02 | 3.54 | |||||
Long-Term Debt / Total Capital | 4.27 | 3.88 | 2.72 | 1.96 | 3.38 | |||||
Total Liabilities / Total Assets | 34.86 | 35.93 | 36.65 | 36.85 | 34.91 | |||||
EBIT / Interest Expense | 75.14 | 66.08 | 96.23 | 134.4 | 122.82 | |||||
EBITDA / Interest Expense | 84.93 | 82 | 113 | 148.53 | 138.41 | |||||
(EBITDA - Capex) / Interest Expense | 81.93 | 73.77 | 105.08 | 140.13 | 133.06 | |||||
Total Debt / EBITDA | 0.2 | 0.25 | 0.16 | 0.1 | 0.15 | |||||
Net Debt / EBITDA | -0.37 | -0.94 | -1.3 | -1.25 | -0.84 | |||||
Total Debt / (EBITDA - Capex) | 0.21 | 0.28 | 0.17 | 0.1 | 0.15 | |||||
Net Debt / (EBITDA - Capex) | -0.38 | -1.05 | -1.4 | -1.33 | -0.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 19.4 | 10.44 | 11.47 | 23.68 | 12.48 | |||||
Gross Profit, 1 Yr. Growth % | 11.25 | -1.12 | 24.83 | 30.29 | 12.93 | |||||
EBITDA, 1 Yr. Growth % | 8.68 | -13.72 | 39.64 | 54.54 | 5.36 | |||||
EBITA, 1 Yr. Growth % | 7.84 | -15.12 | 40.99 | 57.69 | 4.87 | |||||
EBIT, 1 Yr. Growth % | 10.74 | -18.35 | 45.63 | 61.15 | 3.57 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 17.47 | -10.88 | 35.14 | 69.48 | -7.58 | |||||
Net Income, 1 Yr. Growth % | 19.31 | -10.51 | 34.68 | 68.64 | -7.31 | |||||
Normalized Net Income, 1 Yr. Growth % | 20.67 | -18.86 | 44.69 | 64.24 | -1.78 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 19.43 | -10.49 | 34.65 | 68.69 | -7.31 | |||||
Accounts Receivable, 1 Yr. Growth % | 14.96 | 54.25 | 8.86 | 21.01 | -4.82 | |||||
Inventory, 1 Yr. Growth % | 15.41 | 5.14 | 11.79 | 28.34 | 4.57 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.94 | 19.58 | -3.51 | 15.96 | 21.78 | |||||
Total Assets, 1 Yr. Growth % | 15.36 | 19.62 | 13.62 | 24.84 | 4.9 | |||||
Tangible Book Value, 1 Yr. Growth % | -19.77 | 34.77 | 28.58 | 29.98 | -6.27 | |||||
Common Equity, 1 Yr. Growth % | 17.57 | 17.9 | 12.52 | 24.49 | 8.83 | |||||
Cash From Operations, 1 Yr. Growth % | -11.37 | -14.53 | 88.51 | 16.54 | -24.92 | |||||
Capital Expenditures, 1 Yr. Growth % | -4.55 | 154.76 | -3.74 | 22.33 | -27.78 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -38.85 | 39.44 | 42.81 | 24.76 | -36.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -38.46 | 38.67 | 42.34 | 24.69 | -36.23 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 16.67 | 28.57 | 22.22 | 18.18 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.74 | 14.83 | 10.95 | 17.41 | 17.95 | |||||
Gross Profit, 2 Yr. CAGR % | -1.79 | 4.88 | 11.1 | 27.53 | 21.3 | |||||
EBITDA, 2 Yr. CAGR % | -4.16 | -2.1 | 9.77 | 46.9 | 27.6 | |||||
EBITA, 2 Yr. CAGR % | -5.16 | -3.22 | 9.39 | 49.1 | 28.6 | |||||
EBIT, 2 Yr. CAGR % | -3.6 | -4.91 | 9.05 | 53.2 | 29.19 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -1.88 | 2.32 | 9.74 | 51.34 | 25.15 | |||||
Net Income, 2 Yr. CAGR % | -1.59 | 3.33 | 9.79 | 50.71 | 25.02 | |||||
Normalized Net Income, 2 Yr. CAGR % | -1.72 | -1.05 | 8.36 | 54.16 | 27.01 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.47 | 3.39 | 9.79 | 50.71 | 25.04 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.62 | 33.17 | 29.58 | 14.82 | 7.32 | |||||
Inventory, 2 Yr. CAGR % | 10.86 | 10.15 | 8.41 | 19.78 | 15.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -2.03 | 4.92 | 7.42 | 5.78 | 18.83 | |||||
Total Assets, 2 Yr. CAGR % | 13.06 | 17.47 | 16.58 | 19.1 | 14.44 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.85 | 3.99 | 31.64 | 29.28 | 10.37 | |||||
Common Equity, 2 Yr. CAGR % | 15.36 | 17.73 | 15.18 | 18.36 | 16.4 | |||||
Cash From Operations, 2 Yr. CAGR % | 35.32 | -12.96 | 26.93 | 48.22 | -6.46 | |||||
Capital Expenditures, 2 Yr. CAGR % | -37.93 | 55.94 | 56.6 | 8.52 | -6.01 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 548.07 | -7.66 | 41.12 | 33.27 | -10.56 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 880.26 | -7.62 | 40.49 | 33.01 | -10.34 | |||||
Dividend Per Share, 2 Yr. CAGR % | 22.47 | 8.01 | 22.47 | 25.36 | 20.18 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.02 | 5.93 | 13.7 | 15.04 | 15.75 | |||||
Gross Profit, 3 Yr. CAGR % | 3.32 | -1.57 | 11.15 | 17.16 | 22.46 | |||||
EBITDA, 3 Yr. CAGR % | 2 | -6.78 | 10.21 | 23.02 | 31.49 | |||||
EBITA, 3 Yr. CAGR % | 1.14 | -7.9 | 9.71 | 23.57 | 32.6 | |||||
EBIT, 3 Yr. CAGR % | 1.84 | -8.79 | 9.61 | 24.21 | 34.46 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.41 | -4.98 | 12.26 | 26.85 | 28.4 | |||||
Net Income, 3 Yr. CAGR % | 1.58 | -4.66 | 12.87 | 26.67 | 28.16 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.65 | -7.8 | 12.31 | 24.47 | 32.65 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.67 | -4.57 | 12.91 | 26.68 | 28.17 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.39 | 10.38 | 24.51 | 26.69 | 7.86 | |||||
Inventory, 3 Yr. CAGR % | 16.23 | 8.92 | 10.7 | 14.69 | 14.48 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 59.36 | 4.7 | 2.03 | 10.19 | 10.86 | |||||
Total Assets, 3 Yr. CAGR % | 13.48 | 15.21 | 16.17 | 19.28 | 14.17 | |||||
Tangible Book Value, 3 Yr. CAGR % | 20.26 | 13.28 | 11.61 | 31.09 | 16.13 | |||||
Common Equity, 3 Yr. CAGR % | 18.51 | 16.2 | 15.97 | 18.2 | 15.09 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.44 | 16.1 | 12.61 | 23.37 | 18.15 | |||||
Capital Expenditures, 3 Yr. CAGR % | -8.04 | -0.62 | 32.78 | 44.22 | -5.26 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -3.42 | 288.34 | 6.79 | 35.3 | 4.43 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -3.29 | 410.77 | 6.7 | 34.87 | 4.49 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 20.51 | 14.47 | 22.39 | 22.92 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 14.85 | 11.28 | 8.58 | 10.38 | 15.38 | |||||
Gross Profit, 5 Yr. CAGR % | 10.41 | 5.92 | 6.36 | 9.18 | 15.1 | |||||
EBITDA, 5 Yr. CAGR % | 9.49 | 1.06 | 5.5 | 11.82 | 16.86 | |||||
EBITA, 5 Yr. CAGR % | 8.82 | 0.15 | 4.85 | 11.67 | 16.91 | |||||
EBIT, 5 Yr. CAGR % | 8.61 | -0.79 | 4.66 | 12.24 | 17.06 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.46 | 3.41 | 4.66 | 14.47 | 17.25 | |||||
Net Income, 5 Yr. CAGR % | 9.49 | 3.5 | 4.79 | 14.5 | 17.59 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.18 | 0.14 | 4.9 | 13.25 | 17.98 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.55 | 3.57 | 4.84 | 14.57 | 17.62 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.66 | 16.68 | 11.18 | 12.14 | 17.35 | |||||
Inventory, 5 Yr. CAGR % | 18.85 | 19.48 | 13.04 | 13.14 | 12.73 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 48.17 | 49.14 | 36.1 | 5.13 | 8.45 | |||||
Total Assets, 5 Yr. CAGR % | 17.37 | 17.74 | 14.71 | 16.75 | 15.48 | |||||
Tangible Book Value, 5 Yr. CAGR % | 37.82 | 25.51 | 24.69 | 19.43 | 11.11 | |||||
Common Equity, 5 Yr. CAGR % | 22.88 | 21.24 | 17.17 | 17.06 | 16.14 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.66 | -2.81 | 18.03 | 28.02 | 4.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.67 | 30.49 | 13.79 | 2.94 | 15.64 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.47 | 0.01 | 12.4 | 153.18 | -0.59 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.75 | 0.07 | 12.29 | 198.19 | -0.54 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.45 | 6.96 | 8.45 | 22.42 | 16.72 |
- Stock Market
- Stocks
- MYCR Stock
- Financials Mycronic AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















